Electromed (NYSEAMERICAN:ELMD) released its earnings results on Tuesday. The medical equipment provider reported $0.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.01 by $0.11, Fidelity Earnings reports. The firm had revenue of $8.30 million for the quarter.

NYSEAMERICAN:ELMD opened at $9.89 on Friday. Electromed has a 52-week low of $4.75 and a 52-week high of $10.99.

Separately, Dougherty & Co assumed coverage on Electromed in a report on Friday, October 18th. They set a “buy” rating and a $12.00 target price on the stock.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products in the United States and internationally. The company offers SmartVest airway clearance system that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to patients with compromised pulmonary function; and SmartVest SQL System that provides advanced generator programmability and an enhanced pause feature with save, lock, and restore functionality.

Read More: The limitations of an equal weight rating

Earnings History for Electromed (NYSEAMERICAN:ELMD)

Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.